Literature DB >> 14821310

The formation in vivo of noradrenaline from 3:4-dihydroxyphenylserine (noradrenaline carboxylic acid).

C G SCHMITERLOW.   

Abstract

Entities:  

Keywords:  ARTERENOL

Mesh：

Substances：

Year:  1951        PMID： 14821310      PMCID： PMC1509192          DOI： 10.1111/j.1476-5381.1951.tb00628.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  5 in total

1.  The excretion of histamine in urine.

Authors:  G V Anrep; M S Ayadi; G S Barsoum; J R Smith; M M Talaat
Journal:  J Physiol       Date:  1944-09-29       Impact factor: 5.182

2.  The formation of noradrenaline from dihydroxyphenylserine.

Authors:  H BLASCHKO; J H BURN; H LANGEMANN
Journal:  Br J Pharmacol Chemother       Date:  1950-09

3.  Enzymic formation of noradrenaline in mammalian tissue extracts.

Authors:  K H BEYER; H BLASCHKO; J H BURN; H LANGEMANN
Journal:  Nature       Date:  1950-06-10       Impact factor: 49.962

4.  The presence of noradrenaline, adrenaline, and an unknown sympathicolytic factor in cattle heart.

Authors:  M GOODALL
Journal:  Acta Physiol Scand       Date:  1950-03-27

5.  Estimation of adrenaline-noradrenaline mixtures.

Authors:  J H BURN; D E HUTCHEON; R H O PARKER
Journal:  Br J Pharmacol Chemother       Date:  1950-03
  5 in total
  9 in total

1.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

2.  Increase in noradrenaline content of organs after administration of dopa in the cat.

Authors:  U S VON EULER; P UDDEN
Journal:  Experientia       Date:  1951-12

Review 3.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

4.  Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Threo-3,4-dihydroxyphenylserine, a poor source of noradrenaline in the rat.

Authors:  B L Goodwin; R D Johnson; B G Leask; C R Ruthven; M Sandler
Journal:  Experientia       Date:  1972-11-15

6.  [Studies on the physiology and physiopathology of the sympathico-adrenal system by determination of vanillin-mandelic acid excretion in the urine by thin-layer chromatography].

Authors:  E Schmid
Journal:  Arch Kreislaufforsch       Date:  1966-02

7.  Droxidopa in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-19

Review 8.  L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.

Authors:  Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

9.  DL-threo-DOPS as a precursor of noradrenaline.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.